Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 31 (HMGB3P31) is a genomic DNA sequence related to the high mobility group box 3 (HMGB3) gene family but contains disabling mutations that render it non-functional. Like other pseudogenes, it does not produce a functional protein product and is not a drug target, receptor, enzyme, or transporter[2]. Its sequence may be homologous to HMGB3, which is part of the high mobility group protein family involved in chromatin architecture and gene regulation, but HMGB3P31 itself does not participate in cellular functions. There is no evidence of therapeutic, diagnostic, or biomarker use of HMGB3P31.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 31 (HMGB3P31).